News

Stay informed with the latest breaking news, in-depth analysis, and insightful commentary on Stock Market from around the world. Our human-centric cognitive intelligence dedicated team of Author’s delivers accurate and timely reporting on topics stocks and business. Moreover related to forecasting,  management science, new technology, and in-depth current affairs related to Business Management and Forecasting. “Stay Connected Stay Updated”.

US Fed rate-cut intensity is engaging Wall Street, may again create a potentially dangerous situation

by
US Fed rate cut expectations; what strategies should be considered by Investors?

US Market: The recent surge of optimism on Wall Street surrounding potential Federal Reserve interest rate cuts is creating a potentially dangerous situation. While the prospect of lower interest rates can stimulate economic growth and boost stock prices, it’s crucial to recognize the underlying risks:   Premature Expectations: The market’s anticipation of rate cuts might Read more: US Fed rate-cut intensity is engaging Wall Street, may again create a potentially dangerous situation..

Stock Market Live today as on 09 Aug, 2024

by
Stock Market Live today at 09 Aug, 2024

LIC Share at 1,132.15 INR surge +6.55 (0.58%) today  as on 09 Aug, 12:26 pm IST As of August 9, 2024, LIC’s share price is showing positive momentum, currently trading around  ₹1,132.15, up by 0.58% from its opening price. This recent surge is primarily attributed to the company’s strong Q1 results, which have boosted investor confidence. Read more: Stock Market Live today as on 09 Aug, 2024..

Alembic Pharmaceuticals Q1 Reports 12% profit rise amid strong US Market sales

by
Alembic Pharmaceuticals Q1 Reports 12% profit rise amid strong US Market sales

Alembic Pharmaceuticals Limited reported a strong performance in its Q1 results for the period ending June 30, 2024, primarily driven by robust sales in the US market.   Alembic Pharmaceuticals has a strong presence in the US market, which is a key driver for its growth. In Q1 FY25, the company reported a 6% increase Read more: Alembic Pharmaceuticals Q1 Reports 12% profit rise amid strong US Market sales..